U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 198

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr8:19811639
GRCh38:
Chr8:19954128
LPLP184SHyperlipoproteinemia, type IUncertain significance
(Feb 23, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr13:20608428
GRCh38:
Chr13:20034288
ZMYM2S581*, S603*, S668*Hyperlipoproteinemia, type ILikely pathogenic
(Jun 6, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr8:19813394
GRCh38:
Chr8:19955883
LPLH273PHyperlipoproteinemia, type IPathogenicno assertion criteria provided
4.
GRCh37:
Chr8:19813500
GRCh38:
Chr8:19955989
LPLR309fsHyperlipoproteinemia, type IPathogenicno assertion criteria provided
5.
GRCh37:
Chr8:19816769
GRCh38:
Chr8:19959258
LPLCardiovascular phenotypePathogenic
(Dec 23, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr8:19809403
GRCh38:
Chr8:19951892
LPLA125THyperlipidemia, familial combined, LPL related, Hyperlipoproteinemia, type I, not specified
Uncertain significance
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr8:19811777
GRCh38:
Chr8:19954266
LPLV230fsnot provided, Hyperlipidemia, familial combined, LPL related, Hyperlipoproteinemia, type I
Pathogenic/Likely pathogenic
(Sep 29, 2021)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr8:19816875
GRCh38:
Chr8:19959364
LPLN375Dnot specified, Hyperlipidemia, familial combined, LPL related, Hyperlipoproteinemia, type I
Uncertain significance
(Feb 23, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr8:19805844
GRCh38:
Chr8:19948333
LPLG81DHyperlipoproteinemia, type I, Hyperlipidemia, familial combined, LPL relatedPathogenic/Likely pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr8:19813461
GRCh38:
Chr8:19955950
LPLE295DHyperlipoproteinemia, type I, Hyperlipidemia, familial combined, LPL related, not provided
Uncertain significance
(Jan 3, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr8:19811810
GRCh38:
Chr8:19954299
LPLP241SHyperlipoproteinemia, type ILikely pathogeniccriteria provided, single submitter
12.
GRCh37:
Chr8:19813676
GRCh38:
Chr8:19956165
LPLnot providedBenign
(Aug 30, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr8:19805734
GRCh38:
Chr8:19948223
LPLR44SHyperlipoproteinemia, type IUncertain significance
(Jul 22, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr8:19809377
GRCh38:
Chr8:19951866
LPLR116QHyperlipoproteinemia, type ILikely pathogenic
(Jul 22, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr8:19805792
GRCh38:
Chr8:19948281
LPLV64Mnot specified, Hyperlipoproteinemia, type IUncertain significance
(Aug 24, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr8:19819697
GRCh38:
Chr8:19962186
LPLC465SHyperlipoproteinemia, type IUncertain significance
(Jul 14, 2021)
criteria provided, single submitter
17.
GRCh37:
Chr8:19819704
GRCh38:
Chr8:19962193
LPLD467EHyperlipoproteinemia, type IUncertain significance
(Jul 14, 2021)
criteria provided, single submitter
18.
GRCh37:
Chr8:19809322
GRCh38:
Chr8:19951811
LPLA98TCardiovascular phenotype, not provided, Hyperlipoproteinemia, type I,
Hyperlipidemia, familial combined, LPL related, Hyperlipoproteinemia, type I
Likely pathogenic
(Nov 11, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr8:19813628
GRCh38:
Chr8:19956117
LPLnot provided, Hyperlipoproteinemia, type I, Hyperlipidemia, familial combined, LPL related
Benign/Likely benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr8:19811833
GRCh38:
Chr8:19954322
LPLnot providedLikely benign
(Jul 18, 2020)
criteria provided, single submitter
21.
GRCh37:
Chr8:19797023
GRCh38:
Chr8:19939512
LPLnot providedLikely benign
(Aug 22, 2019)
criteria provided, single submitter
22.
GRCh37:
Chr8:19813381
GRCh38:
Chr8:19955870
LPLE269KCardiovascular phenotype, not providedPathogenic
(Jun 29, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr8:19811636
GRCh38:
Chr8:19954125
LPLD183Nnot provided, Hyperlipoproteinemia, type I, Hyperlipidemia, familial combined, LPL related
Pathogenic/Likely pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr8:19813567
GRCh38:
Chr8:19956056
LPLK331EHyperlipoproteinemia, type ILikely pathogenic
(Jun 3, 2020)
criteria provided, single submitter
25.
GRCh37:
Chr8:19810878
GRCh38:
Chr8:19953367
LPLH163YHyperlipoproteinemia, type IUncertain significance
(Jul 16, 2019)
criteria provided, single submitter
26.
GRCh37:
Chr8:19811848-19811849
GRCh38:
Chr8:19954337-19954338
LPLG256fsnot provided, Hyperlipoproteinemia, type IPathogenic
(Jun 19, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr8:19818506
GRCh38:
Chr8:19960995
LPLD412NHyperlipoproteinemia, type IUncertain significance
(Jun 25, 2020)
no assertion criteria provided
28.
GRCh37:
Chr8:19818479
GRCh38:
Chr8:19960968
LPLL403FHyperlipoproteinemia, type IUncertain significance
(Aug 13, 2020)
no assertion criteria provided
29.
GRCh37:
Chr8:19809343
GRCh38:
Chr8:19951832
LPLD105NHyperlipoproteinemia, type IUncertain significance
(Aug 13, 2020)
no assertion criteria provided
30.
GRCh37:
Chr8:19797035
GRCh38:
Chr8:19939524
LPLnot providedLikely benign
(Aug 5, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr8:19816803
GRCh38:
Chr8:19959292
LPLG351RInborn genetic diseases, not provided, Cardiovascular phenotype
Uncertain significance
(Jul 12, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr8:19813505
GRCh38:
Chr8:19955994
LPLC310YHyperlipidemia, familial combined, LPL relatedLikely pathogenic
(Jun 11, 2020)
criteria provided, single submitter
33.
GRCh37:
Chr11:116661451
GRCh38:
Chr11:116790735
APOA5G165AHyperlipoproteinemia, type IUncertain significance
(Mar 5, 2020)
criteria provided, single submitter
34.
GRCh37:
Chr8:19818432-19818433
GRCh38:
Chr8:19960921-19960922
LPLK387fsHyperlipoproteinemia, type ILikely pathogeniccriteria provided, single submitter
35.
GRCh37:
Chr8:19816892
GRCh38:
Chr8:19959381
LPLHyperlipoproteinemia, type I, Cardiovascular phenotypeLikely pathogenic
(Aug 22, 2019)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr8:19824749
GRCh38:
Chr8:19967238
LPLHyperlipoproteinemia, type IBenign
(Jan 12, 2018)
criteria provided, single submitter
37.
GRCh37:
Chr8:19824712
GRCh38:
Chr8:19967201
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
38.
GRCh37:
Chr8:19824707
GRCh38:
Chr8:19967196
LPLHyperlipoproteinemia, type IUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
39.
GRCh37:
Chr8:19824675
GRCh38:
Chr8:19967164
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
40.
GRCh37:
Chr8:19823869
GRCh38:
Chr8:19966358
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
41.
GRCh37:
Chr8:19823724
GRCh38:
Chr8:19966213
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
42.
GRCh37:
Chr8:19819676
GRCh38:
Chr8:19962165
LPLA458VCardiovascular phenotype, Hyperlipoproteinemia, type IUncertain significance
(Sep 15, 2021)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr8:19818468
GRCh38:
Chr8:19960957
LPLI399TCardiovascular phenotype, Hyperlipoproteinemia, type IUncertain significance
(Jul 15, 2021)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr8:19796851
GRCh38:
Chr8:19939340
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
45.
GRCh37:
Chr8:19824618
GRCh38:
Chr8:19967107
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
46.
GRCh37:
Chr8:19824614
GRCh38:
Chr8:19967103
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr8:19824609
GRCh38:
Chr8:19967098
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr8:19824570
GRCh38:
Chr8:19967059
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr8:19824564
GRCh38:
Chr8:19967053
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr8:19823652
GRCh38:
Chr8:19966141
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
51.
GRCh37:
Chr8:19823550
GRCh38:
Chr8:19966039
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
52.
GRCh37:
Chr8:19811737
GRCh38:
Chr8:19954226
LPLnot provided, Hyperlipoproteinemia, type IConflicting interpretations of pathogenicity
(Jun 1, 2022)
criteria provided, conflicting interpretations
53.
GRCh37:
Chr8:19810892
GRCh38:
Chr8:19953381
LPLnot provided, Hyperlipoproteinemia, type IConflicting interpretations of pathogenicity
(Feb 5, 2022)
criteria provided, conflicting interpretations
54.
GRCh37:
Chr8:19824368
GRCh38:
Chr8:19966857
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
55.
GRCh37:
Chr8:19824235
GRCh38:
Chr8:19966724
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
56.
GRCh37:
Chr8:19824220
GRCh38:
Chr8:19966709
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
57.
GRCh37:
Chr8:19824215
GRCh38:
Chr8:19966704
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
58.
GRCh37:
Chr8:19823469
GRCh38:
Chr8:19965958
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
59.
GRCh37:
Chr8:19823368
GRCh38:
Chr8:19965857
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr8:19823276
GRCh38:
Chr8:19965765
LPLHyperlipoproteinemia, type IUncertain significance
(Apr 28, 2017)
criteria provided, single submitter
61.
GRCh37:
Chr8:19823210
GRCh38:
Chr8:19965699
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
62.
GRCh37:
Chr8:19810830
GRCh38:
Chr8:19953319
LPLN147HHyperlipoproteinemia, type IUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
63.
GRCh37:
Chr8:19824208
GRCh38:
Chr8:19966697
LPLHyperlipoproteinemia, type ILikely benign
(Jan 12, 2018)
criteria provided, single submitter
64.
GRCh37:
Chr8:19824194
GRCh38:
Chr8:19966683
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr8:19823042
GRCh38:
Chr8:19965531
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
66.
GRCh37:
Chr8:19822956
GRCh38:
Chr8:19965445
LPLHyperlipoproteinemia, type IUncertain significance
(Apr 28, 2017)
criteria provided, single submitter
67.
GRCh37:
Chr8:19822850
GRCh38:
Chr8:19965339
LPLHyperlipoproteinemia, type IBenign
(Jan 12, 2018)
criteria provided, single submitter
68.
GRCh37:
Chr8:19819745
GRCh38:
Chr8:19962234
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
69.
GRCh37:
Chr8:19805851
GRCh38:
Chr8:19948340
LPLHyperlipoproteinemia, type IUncertain significance
(Apr 28, 2017)
criteria provided, single submitter
70.
GRCh37:
Chr8:19805736
GRCh38:
Chr8:19948225
LPLT45Nnot provided, Hyperlipoproteinemia, type I, not specified
Uncertain significance
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr8:19797032
GRCh38:
Chr8:19939521
LPLCardiovascular phenotype, Hyperlipoproteinemia, type I, not provided
Conflicting interpretations of pathogenicity
(Aug 24, 2022)
criteria provided, conflicting interpretations
72.
GRCh37:
Chr8:19796987
GRCh38:
Chr8:19939476
LPLHyperlipoproteinemia, type IUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
73.
GRCh37:
Chr8:19813411
GRCh38:
Chr8:19955900
LPLL279Vnot provided, Hyperlipidemia, familial combined, LPL related, Hyperlipoproteinemia, type I,
Hyperlipoproteinemia, type I
Pathogenic
(Nov 29, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr8:19813412
GRCh38:
Chr8:19955901
LPLL279Rnot provided, Hyperlipoproteinemia, type IPathogenic
(Jun 23, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr8:19819647
GRCh38:
Chr8:19962136
LPLnot providedLikely benign
(Aug 30, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr8:19805713
GRCh38:
Chr8:19948202
LPLnot provided, Cardiovascular phenotypeLikely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr8:19819641
GRCh38:
Chr8:19962130
LPLHyperlipidemia, familial combined, LPL related, Hyperlipoproteinemia, type I, not provided,
Cardiovascular phenotype
Likely benign
(Aug 10, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr8:19819628
GRCh38:
Chr8:19962117
LPLV442GHyperlipidemia, familial combined, LPL related, Hyperlipoproteinemia, type I, not provided,
Hyperlipoproteinemia, type I
Conflicting interpretations of pathogenicity
(Oct 28, 2022)
criteria provided, conflicting interpretations
79.
GRCh37:
Chr8:19809306
GRCh38:
Chr8:19951795
LPLCardiovascular phenotype, not providedBenign/Likely benign
(Sep 28, 2022)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr8:19805791
GRCh38:
Chr8:19948280
LPLCardiovascular phenotype, not provided, Hyperlipoproteinemia, type I
Conflicting interpretations of pathogenicity
(Oct 14, 2022)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr8:19805714
GRCh38:
Chr8:19948203
LPLE38Knot specified, Hyperlipoproteinemia, type I, not provided
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
82.
GRCh37:
Chr8:19811623
GRCh38:
Chr8:19954112
LPLnot providedBenign
(Nov 1, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr8:19797010
GRCh38:
Chr8:19939499
LPLA20Vnot providedLikely benign
(Sep 23, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr8:19813476
GRCh38:
Chr8:19955965
LPLnot providedLikely benign
(Oct 4, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr8:19810919
GRCh38:
Chr8:19953408
LPLCardiovascular phenotype, not provided, Hyperlipoproteinemia, type I
Conflicting interpretations of pathogenicity
(Oct 7, 2022)
criteria provided, conflicting interpretations
86.
GRCh37:
Chr8:19816880
GRCh38:
Chr8:19959369
LPLnot provided, Cardiovascular phenotypeBenign/Likely benign
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr8:19811776
GRCh38:
Chr8:19954265
LPLCardiovascular phenotype, not provided, Hyperlipoproteinemia, type I
Conflicting interpretations of pathogenicity
(Oct 14, 2022)
criteria provided, conflicting interpretations
88.
GRCh37:
Chr8:19818544
GRCh38:
Chr8:19961033
LPLnot providedLikely benign
(Sep 3, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr8:19809320
GRCh38:
Chr8:19951809
LPLA97VCardiovascular phenotype, not provided, Hyperlipoproteinemia, type I
Conflicting interpretations of pathogenicity
(Sep 13, 2022)
criteria provided, conflicting interpretations
90.
GRCh37:
Chr8:19810847
GRCh38:
Chr8:19953336
LPLCardiovascular phenotype, not provided, Hyperlipoproteinemia, type I
Benign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr8:19809375
GRCh38:
Chr8:19951864
LPLCardiovascular phenotype, not provided, Hyperlipoproteinemia, type I
Conflicting interpretations of pathogenicity
(Oct 20, 2022)
criteria provided, conflicting interpretations
92.
GRCh37:
Chr8:19813374
GRCh38:
Chr8:19955863
LPLCardiovascular phenotype, not providedLikely benign
(Oct 9, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr8:19813574
GRCh38:
Chr8:19956063
LPLR333HHyperlipoproteinemia, type I, Hyperlipidemia, familial combined, LPL related, Cardiovascular phenotype,
not provided
Conflicting interpretations of pathogenicity
(Mar 8, 2023)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr8:19813360
GRCh38:
Chr8:19955849
LPLQ262*Hyperlipoproteinemia, type I, Hypertriglyceridemia, not provided
Conflicting interpretations of pathogenicity
(Jan 22, 2020)
criteria provided, conflicting interpretations
95.
GRCh37:
Chr8:19813373
GRCh38:
Chr8:19955862
LPLC266YHyperlipoproteinemia, type ILikely pathogenic
(Dec 3, 2017)
criteria provided, single submitter
96.
GRCh37:
Chr8:19805815
GRCh38:
Chr8:19948304
LPLH71Qnot providedConflicting interpretations of pathogenicity
(Oct 31, 2022)
criteria provided, conflicting interpretations
97.
GRCh37:
Chr8:19816888
GRCh38:
Chr8:19959377
LPLT379Inot provided, Hyperlipoproteinemia, type I, Cardiovascular phenotype
Conflicting interpretations of pathogenicity
(Oct 18, 2022)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr8:19816887
GRCh38:
Chr8:19959376
LPLT379Anot provided, Hyperlipoproteinemia, type I, Cardiovascular phenotype,
not specified
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr8:19824669
GRCh38:
Chr8:19967158
LPLnot provided, Hyperlipoproteinemia, type IBenign
(Aug 30, 2018)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr8:19824667
GRCh38:
Chr8:19967156
LPLnot provided, Hyperlipoproteinemia, type IBenign
(Aug 30, 2018)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination